Anti-Infectives
A Global Strategic Business Report
MCP-6156
RESEARCH TRANSCRIPTS | |
---|---|
“Structure-based drug design: Towards new anti-infectives” by Professor Ehmke Pohl
MY SILO
DESCRIPTION:
COMSTECH- NDT lecture : “Structure-based drug design: Towards new anti-infectives” by Professor Ehmke Pohl Feb 2, 2022
TRANSCRIPT:
|
|
NIAID Resources to Facilitate Discovery & Development of Anti Infectives
MY SILO
DESCRIPTION:
Recording of the live webinar, broadcast on 21 February 2019 NIAID Resources to Facilitate Discovery & Development of Anti-Infectives Speakers: Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID), Dan Pevear (VenatoRx Pharmaceuticals) In this webinar, Ann Eakin provided an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines and diagnostics targeting infectious diseases. Ann’s presentation was complemented by a short presentation by Dan Pevear, in which he will share VenatoRx’ experience with NIAID support mechanisms. The presentations were followed by a Q&A session. REVIVE: https://revive.gardp.org/ GARDP: https://www.gardp.org/
TRANSCRIPT:
|
|
New Anti-Infectives, and Why We Need Them
MY SILO
DESCRIPTION:
DERM2022: New Anti-Infectives, and Why We Need Them - Ted Rosen, MD, FAAD (Infectious Disease)
TRANSCRIPT:
|
|
Overview of Anti-infectives
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Joshua McClure - Antimicrobial Peptoids: Next Generation Anti-infectives
MY SILO
DESCRIPTION:
MaxWell Bioscience's mission is to prove our disruptive new "peptoid" anti-infectives destroy humanity's top threat - highly infectious pandemic microbes - like untreatable viruses, drug-resistant bacteria, and drug-resistant fungi. Maxwell's anti-infectives have been shown by multiple independent labs (including Stanford, NYU and others) to be rapid killers of the worst viruses, drug-resistant fungi and treatment-resistant bacteria. These labs show Maxwell peptoids are highly selective for pathogens over human cells, are biostable, effective at low doses, and rapidly destroy biofilm defenses. MaxWell Bioscience are in preclinical stage now, preparing for human trials. https://maxwellbiosciences.com Joshua McClure is Founder and CEO of MaxWell Biosciences. Joshua has co-invented and secured over a dozen patents in the areas of multi-tissue regeneration and gene expression modulation in collaboration with co-inventors at Stanford University, and University of California Berkeley. McClure leads a team of some of the world's top scientists and clinicians in the field of tissue regeneration, using computational systems medicine to personalize therapies. A graduate of the USAF Academy, McClure has been a leader of tech companies for over 15 years and comes to industry with a background in top secret USAF projects. He has invented multiple new category-first companies, revolutionary new technologies and now devotes his time to biotechnologies with the capacity to reverse age-related degeneration, and optimize human longevity. MaxWell is working with Mayo Clinic, The American Red Cross and others to bring these technologies to humans. https://www.linkedin.com/in/joshuamcclure Many thanks for watching! Consider supporting SciFuture by: a) Subscribing to the SciFuture YouTube channel: http://youtube.com/subscription_center?add_user=TheRationalFuture b) Donating - Bitcoin: 1BxusYmpynJsH4i8681aBuw9ZTxbKoUi22 - Etheriem: 0xd46a6e88c4fe179d04464caf42626d0c9cab1c6b - Patreon: https://www.patreon.com/scifuture c) Sharing the media SciFuture creates: http://scifuture.org Kind regards, Adam Ford - Science, Technology & the Future
TRANSCRIPT:
|
|
Applying the breakthrough therapy criteria: Anti-infective/psychiatry/hematology
MY SILO
DESCRIPTION:
On April 24, under a cooperative agreement with FDA, the Center for Health Policy convened a public meeting to discuss the qualifying criteria for breakthrough therapy designation (BTD). http://www.brookings.edu/events/2015/04/24-fda-breakthrough-therapy-criteria Subscribe! http://www.youtube.com/subscription_center?add_user=BrookingsInstitution Follow Brookings on social media! Facebook: http://www.Facebook.com/Brookings Twitter: http://www.twitter.com/BrookingsInst Instagram: http://www.Instagram.com/brookingsinst LinkedIn: http://www.linkedin.com/com/company/the-brookings-institution
TRANSCRIPT:
|
|
Urinary tract anti infective agents || Medicinal Chemistry 3 || Pharmacology 6th semester
MY SILO
DESCRIPTION:
In this Video we Cover, Urinary tract anti infective agents , medicinal chemistry 6th semester , Must watch :- Part 1 :- https://youtu.be/zU_m6gO-8GI Part 2 (MOA) :- https://youtu.be/ZEKbbqjxkrE website for Notes & more :- https://www.carewellpharma.in join telegram group :- https://telegram.me/carewellpharma Playlists for 6th sem video lectures :- 1. Medicinal chemistry 6th sem :- https://youtube.com/playlist?list=PLQnNyE1lxfVKARvesJ9wnKD6cX1gLum45 2. Pharmacology 6th semester :- https://youtube.com/playlist?list=PLQnNyE1lxfVJ_ds9XqfBMiEJuw6qO4gQW 3. Pharmaceutical Biotechnology 6th Sem :- https://youtube.com/playlist?list=PLQnNyE1lxfVJeyPkYzYziZnOOu8MY1owA Watch some informative videos - 1. B Pharmacy pass fail system | b pharmacy passing marks | b pharmacy exam pattern | Carewell Pharma :- https://youtu.be/fd7JNvH7YOk 2. How to write Exam Sheet in Pharmacy | End semester Exam | B pharmacy | exam tips | Carewell Pharma :- https://youtu.be/uM7xoHMRRlA 3. Tips on how to study in pharmacy || 10 Most Important Points || Carewell Pharma :- https://youtu.be/4xQ0FljPYb0 4. 10 Smart Study Tips || Carewell Pharma :- https://youtu.be/CN1o6YgRGyk website for Notes & more :- https://www.carewellpharma.in join telegram group :- https://telegram.me/carewellpharma Carewell Classes :- https://youtube.com/c/CarewellClasses Like, Share And Subscribe Our Channel For More Videos :- https://www.youtube.com/c/Carewellpharma subscribe to our channel and press the bell icon to get the latest updates of our videos. Share this video. Watch other semester videos :- https://www.youtube.com/c/Carewellpharma/playlists --------------------------------------------------------------------------- Connect with Us :- Website (B Pharmacy Notes & More) :- https://www.carewellpharma.in B Pharmacy Quiz :- https://www.carewellpharma.in/quiz Join telegram for Updates :- https://telegram.me/carewellpharma Instagram :- https://www.instagram.com/carewellpharma About us :- Carewell Pharma is a Youtube Channel, which provides you a free Video lectures regarding b Pharmacy (Regular According to PCI) and also some tips which helps you in study.. Also provide - Website :- https://www.carewellpharma.in B Pharmacy Notes :- https://carewellpharma.in/B_Pharmacy/Notes/ B Pharmacy Quiz :- https://www.carewellpharma.in/quiz/ Syllabus :- https://carewellpharma.in/B_Pharmacy/Syllabus/ B Pharmacy Mcqs :- https://carewellpharma.in/B_Pharmacy/MCQs/ Practical files pdf :- https://carewellpharma.in/B_Pharmacy/Practical/ Question papers :- https://carewellpharma.in/B_Pharmacy/QuestionPapers/ B Pharmacy Books :- https://carewellpharma.in/B_Pharmacy/Books/ Blogs (mcqs + theory) :- https://www.carewellpharma.in/blog/ Subscribe us on Youtube :- https://www.youtube.com/c/Carewellpharma Thank You Everyone 🙏❤ -- Carewell Pharma -- --------------------------------------------------------------------------- Queries - carewell pharma, medicinal chemistry 6th semester, b pharmacy 6th semester, b pharmacy 6th sem, b pharm 6th semester, 6 sem b pharmacy medicinal chemistry , b pharmacy 6th sem medicinal chemistry, b pharmacy 6th semester medicinal chemistry unit 3 , Urinary tract anti infective agents , urinary tract anti infective agents medicinal chemistry 6th sem, classification of urinary tract anti infective agents, sar of quinolones, mechanism of action of quinolones, 6th semester carewell pharma, carewell pharma 6th semester medicinal chemistry unit 3 , synthesis of nitrofurantoin, medicinal chemistry 6th semester unit 3, medicinal chemistry 6th semester carewell pharma, medicinal chemistry 6th semester unit 3 carewell pharma, #carewellpharma #antiviral #medicinalchemistry #bpharm6thsem
TRANSCRIPT:
|
|
LEEFORD GENERIC ANTI BIOTICS ANTI INFECTIVE RANGE CATALOG
MY SILO
DESCRIPTION:
anti biotics amoxyclav amoxicillin cefexim cefopodoxim cefuroxim azithromycine ciptlrofloxacin ofloxacine many more
TRANSCRIPT:
|
|
TEVA Stock | Teva Pharmaceutical Industries Limited Q4 2020 Earnings Call
MY SILO
DESCRIPTION:
Access earnings conference call transcripts at: https://news.alphastreet.com/earnings-call-transcripts/ Earnings Calendar: https://news.alphastreet.com/earnings-calendar/ Earnings Infographics: https://news.alphastreet.com/infographics/ Listen on: https://podcasts.apple.com/us/podcast/the-earnings-podcast-from-alphastreet/id1535892241?uo=4 https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6kl1lpewQcWDvHJ0 https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy8zODY2ZmUwOC9wb2RjYXN0L3Jzcw== https://radiopublic.com/the-earnings-podcast-from-alphast-Gq2Bpo Follow us on: https://twitter.com/AlphSt_Live https://twitter.com/_AlphaStreet https://www.facebook.com/AlphaStreetinc https://www.linkedin.com/company/alphastreet http://www.google.com/news/s/CAowj7D0Cg https://apple.news/TZOi1Q735Ty-T4dxalibGNw Subscribe this channel to listen to earnings call audios
TRANSCRIPT:
|
|
Teva Pharmaceutical Industries Limited TEVA CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Con
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
First Distinguished Bristol-Myers Squibb Lecture in Immunology
MY SILO
DESCRIPTION:
Lecture delivered on June 17, 2010. This is the first Distinguished Lecture in Immunology supported by Bristol-Myers Squibb. UC Irvine Institute For Immunology presents Michael D. Cahalan, Ph.D., Professor and Chair Department of Physiology and Biophysics Institute for Immunology University of California, Irvine.
TRANSCRIPT:
|
|
BMY Stock | Bristol Myers Squibb Co Q2 2020 Earnings Conference Call
MY SILO
DESCRIPTION:
Bristol-Myers Squibb Co (BMY) Q2 2020 Earnings Report https://news.alphastreet.com/earnings-bristol-myers-squibb-company-nyse-bmy-reports-q2-2020-results/
TRANSCRIPT:
|
|
We have an accelerated opportunity to renew our portfolio, says Bristol Myers Squibb CEO
MY SILO
DESCRIPTION:
Dr. Giovanni Caforio, Bristol Myers Squibb CEO, joins the 'Halftime Report' to discuss his company's collaboration with Century Therapeutics. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV
TRANSCRIPT:
|
|
THALIA MINGO | Global Lead Bristol Myers Squibb Network of women ( B_Now)
MY SILO
DESCRIPTION:
This special meeting on Women Inspiring a Peaceful & Sustainable Future was hosted by CSPOC at United Nations of Geneva. The event was directed and curated by Kristin Engvig and produced by GCF & WIN. GCF and WIN have worked together since 2019 and their women pioneering global change initiative includes the 16th May 2022 and the 11th May 2023 meeting in Geneva. It will conclude in New York in 2024
TRANSCRIPT:
|
|
2016 WMIF | Fireside Chat: Giovanni Caforio, MD, CEO, Bristol-Myers Squibb
MY SILO
DESCRIPTION:
Introduction by: Thomas Lynch, MD, CEO, Mass General Physician's Organization Moderator: Meg Tirrell, Biotech and Pharma Reporter, CNBC Giovanni Caforio, MD, CEO, Bristol-Myers Squibb
TRANSCRIPT:
|
|
AWS re:Inforce 2022 - Bristol Myers Squibb: Automate multi-account, FinOps, security & DevOps
MY SILO
DESCRIPTION:
As organizations move more workloads to the cloud, they have a growing need for security and governance. Cloud teams are asked to use new AWS Regions and services while meeting the compliance needs of the business. In this session, Bristol Myers Squibb, a leading global life sciences company, dives deep into how they have implemented a fully automated self-service platform. Learn how they enabled self-service for all business users, centrally managed network and data resources, and automated governance. Also learn how they used AWS Control Tower and AWS Service Catalog to support controls and deliver best practice kits in their cloud environment. (GRC-202) Learn more about AWS re:Inforce at https://bit.ly/3baitIT. Subscribe: More AWS videos http://bit.ly/2O3zS75 More AWS events videos http://bit.ly/316g9t4 ABOUT AWS Amazon Web Services (AWS) hosts events, both online and in-person, bringing the cloud computing community together to connect, collaborate, and learn from AWS experts. AWS is the world’s most comprehensive and broadly adopted cloud platform, offering over 200 fully featured services from data centers globally. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—are using AWS to lower costs, become more agile, and innovate faster. #reInforce2022 #CloudSecurity #AWS #AmazonWebServices #CloudComputing
TRANSCRIPT:
|
|
Krishna Cheriath, Bristol Myers Squibb | MITCDOIQ 2020
MY SILO
DESCRIPTION:
Krishna Cheriath sits down with Dave Vellante for a digital CUBE Conversation as part of the MIT CDOIQ 2020 Symposium
TRANSCRIPT:
|
|
Intellectual Property Protection for Life Science AI Assets with Bristol Myers Squibb
MY SILO
DESCRIPTION:
E. Jay Wilusz, Senior Corporate Counsel, Bristol Myers Squibb AI continues to increase the speed and efficiency of the entire bandwidth of pharmaceutical interests. Those interests include drug discovery, clinical data processing, and digital interfaces between patients and providers to improve treatment outcomes. How should nascent and established companies protect their AI and ML intellectual property assets? I will describe how to balance patent protection or secrecy agreements against the need to publicize technology improvements, technology lifespan, and the ability to monitor for infringement and defend IP rights.
TRANSCRIPT:
|
|
AWS re:Invent 2019: Data lakes reimagined: Efficiency & innovation at Bristol-Myers Squibb (LFS204)
MY SILO
DESCRIPTION:
The increasing amount of data available to pharmaceutical companies creates pressure on R&D teams to orchestrate and analyze that data and generate insights that will help patients prevail over serious diseases. In this session, learn how Bristol-Myers Squibb used AWS services to create a platform-based approach for ingesting, preparing, curating, and persisting business-critical data for digital integration, analytics, and insights generation. Hear how this approach has improved the company’s efficiency, enhanced cost savings, and decreased the time-to-service for its data customers. Additionally, gain an understanding of the lessons learned from this process, and learn best practices for other organizations.
TRANSCRIPT:
|
|
Rev 1 "Keynote: Deciphering Modern Cancer Therapy with Bioinformatics" - Bristol Myers Squibb
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Immutep (ASX:IMM, NASDAQ:IMMP) LAG-3 validated in Bristol Myers Squibb trial
MY SILO
DESCRIPTION:
29 Mar 2021 - Immutep Limited (ASX:IMM, NASDAQ:IMMP) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
TRANSCRIPT:
|
|
Benchling Virtual Launch Event – Fireside Chat with Dr. Kristen Hege of Bristol Myers Squibb
MY SILO
DESCRIPTION:
Kristen Hege, M.D., is Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, at Bristol Myers Squibb. At Benchling’s virtual launch event, Dr. Hege discussed her 30+ year hybrid academic/industry career in cell therapy, from the emergence of the field during the AIDS crisis in the ‘90s, to incredible outcomes in patients with blood cancers in the 2010s, and the approval of the first BCMA CAR T product in 2021. —————————— Benchling is the pioneer of the R&D Cloud, software that powers the biotechnology industry. More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling’s R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D Cloud helps these organizations modernize their scientific processes and accelerate collaboration so they can convert the complexity of biology into world-changing results. To learn more, visit https://www.benchling.com/
TRANSCRIPT:
|
|
UGM2020 / 24. iRODS at Bristol Myers Squibb: Leveraging iRODS for scientific applications in AWS
MY SILO
DESCRIPTION:
Mohammad Shaikh, Bristol Myers Squibb Oleg Moiseyenko, Bristol Myers Squibb June 11, 2020 - Virtual https://irods.org/ugm2020
TRANSCRIPT:
|
|
Shalu Chadha, Accenture & Kathleen Natriello, Bristol-Myers Squibb | AWS Executive Summit 2018
MY SILO
DESCRIPTION:
Shall Chadha, Sr. Technology Services Lead, Accenture & Kathleen Netriello, Vice President and Head of IT Digital Design, Bristol Myers-Squibb sit down with Rebecca Knight t the AWS Executive Summit at AWS re:Invent. #AWS #theCUBE #AWSSummit https://siliconangle.com/2018/12/27/cloud-ai-services-dose-big-pharma-with-overdue-speed-agility-reinvent/ Cloud AI services dose big pharma with overdue speed, agility What industry could stand to pick up its pace more than pharmaceutical research? Look at the price of drugs in the U.S. It can take over 10 years and billions of dollars to develop one pill. Providing insight and historical context, modern machine-learning technologies could make pharma a more efficient industry. Bristol-Myers Squibb Co. is adopting cloud technologies to speed up research into immuno-oncology therapies. These treatments boost the immune system in order to fight cancer. “Our highest priority was our scientists’ productivity,” said Kathleen Natriello (pictured, right), vice president of corporate information technology at Bristol-Myers Squibb. BMS has teamed up with Amazon Web Services Inc. and Accenture LLP to develop solutions for its scientists and business units. Genomics research requires huge volumes of data. With machine learning and artificial intelligence services from AWS, BMS scientists have drastically reduced the time it takes to process them. Natriello and Shalu Chadha (pictured, left), technology lead, products North East North America, at Accenture, spoke with Rebecca Knight (@knightrm), host of theCUBE, SiliconANGLE Media’s mobile livestreaming studio, during the AWS Executive Summit in Las Vegas. They discussed how the three-way partnership is injecting speed and agility into typically glacier-paced pharma processes. (* Disclosure below.) It’s about time for agility in pharma BMS has implemented several AWS cloud services that enable scientists to use AI for computational approaches and simulations. They slash the time and cost required to complete an experiment, according to Natriello. “They no longer have to use actual physical material or patients or investigators. They can do it all through simulation and modelling,” she said. It uses AI-powered robotics process automation across legal and compliance, and is now starting to use them in clinical trials. It is trying to become “quicker with how the patients are going to see both responses to adverse events, as well as how do you accelerate the clinical trial process,” Chadha said. Scientists are the biggest advocates for the introduction of new tech, according to Natriello. “They are doing things with machine learning and artificial intelligence with these simulations … in a few hours that used to take them weeks and months,” she stated. Business functions are enthusiastically on-board as well. “Very often, the business functions are the ones that introduce the new technologies, because they’re really interested in it,” Natriello concluded. Watch the complete video interview below, and be sure to check out more of SiliconANGLE’s and theCUBE’s coverage of the AWS Executive Summit. (* Disclosure: TheCUBE is a paid media partner for the AWS Executive Summit event. Neither Accenture LLP, the event sponsor, nor other sponsors have editorial control over content on theCUBE or SiliconANGLE.)
TRANSCRIPT:
|
|
Day 2 - Track 1 - Bristol Myers Squibb Commitment to Addressing Health Disparities and Diversity
MY SILO
DESCRIPTION:
Sign up for our next summit for free here: https://bit.ly/PTFSummit Bristol Myers Squibb recognizes and celebrates the diverse experiences and views of their workforce. They encourage every employee to bring their authentic selves to work so they can fully engage in a meaningful way and drive the company's mission to help patients prevail over serious diseases. Bristol Myers Squibb's PRIDE Alliance is a vital part of that effort, helping to ensure a diverse and inclusive culture that empowers LGBTQ+ inclusion, awareness, and engagement. For this roundtable discussion, we are joined by several BMS leaders to share their career journeys and take a deep dive into BMS's Heath Equity approach and work including how prior partnerships with HIV and LGBTQ+ communities became the playbook for the current initiatives. PowerToFly's Meg Alexander will moderate. Sign up for our next summit for free here: https://bit.ly/PTFSummit
TRANSCRIPT:
|
|
ACP Presents: Careers at Bristol Myers Squibb
MY SILO
DESCRIPTION:
On April 21st, Bristol Myers Squibb joined ACP in hosting a "Careers At BMS" webinar for interested veteran and military spouse Protégés. The event featured a panel of BMS employees who spoke about company culture, job opportunities, and their own personal transitions from the military to Corporate America. The event closed with a Q&A session from the 85-person virtual audience. Many thanks to Marty, Pat, Ricardo, Kristen and Marissa for a terrific event!
TRANSCRIPT:
|
|
The Bluey Webinar Series - Epoxy Resin Technology with Max Simmons, Founder of EpiMax
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Steve Goldman Art of the Drill
MY SILO
DESCRIPTION:
Steve Goldman discusses how to have a safe, effective drill for your hospital or healthcare facility. Due to the new CMS Emergency Preparedness Guidelines set to be in full effect by November 2017, many emergency planners are looking at ways to improve their drills. Steve has lots of ideas to reviewing and improving your drills to ensure everyone is safe during an incident.
TRANSCRIPT:
|
|
IPC London Sunday Message - Pr Thomas Philip on 09/06/2019
MY SILO
DESCRIPTION:
IPC London Sunday Message by Guest speaker Pastor Thomas Philip Venmany (IPC General Joint Secretary)
TRANSCRIPT:
|
|
Bebi philip - On Va Piétiner ft. KOFFI OLOMIDE
MY SILO
DESCRIPTION:
Music video for On Va Piétiner ft KOFFI OLOMIDE performed by Bebi philip. https://www.youtube.com/channel/UCcVJuyx_vU96hlCMD4zm_Ig https://instagram.com/bebi.philip.5 https://itunes.apple.com/fr/artist/bebi-philip/id425092975 Copyright (C) 2016 BBP Team Records. --- Powered by http://www.vydia.com http://vevo.ly/P9BrDU
TRANSCRIPT:
|
|
Crisis Management & Business Resiliency with MIT's Dr. Steve Goldman
MY SILO
DESCRIPTION:
Subscribe to the Disaster Empire Website newsletter and follow my blogs at: www.disasterempire.com Ashley Goosman's LinkedIn Profile: www.linkedin.com/in/ashley-goosman Dr. Steve's Profile - linkedin.com/in/dr-steve-goldman-5668844 Crisis Management and Business Resiliency, Advanced Business Resiliency: web.mit.edu/professional/short-programs/courses/crisis_management.html Consulting: SteveGoldmanAssociates.com (Company) More link's to a sampling of Ashley's works: DRJ Career Spotlight: Career Spotlight – https://drj.com/journal_main/career-spotlight-ashley-goosman/ Business Continuity Institute (BCI): Engaging with others is invaluable for your career: https://www.thebci.org/news/engaging-with-others-is-invaluable-for-your-career-interview-with-ashley-goosman.html Continuity Insights: https://continuityinsights.com/the-end-of-business-continuity-as-we-know-it/ If you are interested in sponsoring an upcoming video, being a guest on the channel, or partnering on future blogs, contact me at info@disasterempire.com #massachusettsinstituteoftechnology #education #certification #crisismanagement #resilience #businessresilience #businesscontinuity
TRANSCRIPT:
|
|
Tina Philip on her wedding with Nikhil Sharma getting postponed due to Coronavirus | Exclusive
MY SILO
DESCRIPTION:
'Ek Bhram Sarvagun Sampanna' actress Tina Philip recently postponed her wedding with fiance Nikhil Sharma due to Coronavirus outbreak and she shares how the feeling was like and what precautions she is taking currently. Watch the video to know more. #TinaPhilip #NikhilSharma #SarvagunSampanna
TRANSCRIPT:
|
|
Davie Philip on grassroots empowerment in tackling the Climate Emergency-SCCAN General Assembly 2020
MY SILO
DESCRIPTION:
Scottish Communities Climate Action Network General Assembly 13 September 2020 Our community’s chance to steer our support and decide SCCAN’s priority for activities. We explored: Storytelling, Podcasts, Regional Gatherings, Local Zero Carbon Plans, Governance skills and Fundraising. Our keynote speaker is Davie Philip - a Scottish activist who's been advocating for sustainable community in Ireland for over 20 years. He hosts events and facilitates groups - working on collaborative approaches to help their localities flourish - through Cultivate, the trading name of the Sustainable Ireland Cooperative Society he co-founded in 2000. Davie - based at WeCreate, an ecosystem of innovation in Cloughjordan Ecovillage - has served on the Council of ECOLISE, the European network for community-led initiatives on climate change and sustainability for 4 years. He was elected as an ECOLISE co-president - along with Francesca Whitlock of Global Ecovillage Network (GEN) Europe - in 2019. We heard Davie Philip's Presentation on grassroots empowerment in tackling the Climate and Ecological Emergency. Davie is a Scottish activist who's been advocating for a sustainable community in Ireland for over 20 years. He facilitates groups working on collaborative approaches to help localities flourish - through Cultivate, the trading name of the Sustainable Ireland Cooperative Society he co-founded in 2000. Read the full event's report here: https://bit.ly/sccanga13sept Communities for Future website: https://events.communitiesforfuture.org/ http://www.cultivate.ie/about-cultivate-new/our-people http://www.resilience.cultivate.ie/ Scottish Communities Climate Action Network - a network of community groups and organisations taking action on climate change. Our Purpose: To inspire and promote, connect and support community-led action in Scotland to address the Climate Emergency https://www.scottishcommunitiescan.org.uk/
TRANSCRIPT:
|
|
Yale Zhang | Mella Pet Care - Innovations in Workflow Through Connected Devices - Episode 94
MY SILO
DESCRIPTION:
Taking a pet's temperature and having that information automatically added to their medical record would be a huge efficiency gain. This week, Shawn & Ivan chat with Yale Zhang of Mella Pet Care about innovations in workflow through connected devices. Yale recommends Smart People Should Build Things by Andrew Yang (amzn.to/3eq76Kv). Learn more about Yale at mella.ai. 👉 Mentioned in This Episode: - Launching a New Startup With the Same Team - Connecting Medical Devices to Practice Management Software - Creating Devices for Both Veterinarians and Pet Parents Our website: https://www.veterinaryinnovationpodcast.com/ Subscribe: Apple Podcasts - https://apple.co/2Y9joNR Google Podcasts - http://bit.ly/2X36dMZ Google Play - http://bit.ly/2XxdskI Spotify - https://spoti.fi/2KzSw6x Stitcher - http://bit.ly/2Y4ZK5H
TRANSCRIPT:
|
|
SelectUSA 2023 Preparation a Visit with Mark Sullivan, MA Office of International Trade & Investment
MY SILO
DESCRIPTION:
Mark Sullivan, mark.f.sullivan@state.ma.us MA Office of International Trade & Investment (MOITI), https://www.mass.gov/orgs/massachusetts-office-of-international-trade-and-investment .. SelectUSA Summit, 1-4 May 2023, Washington, DC https://www.selectusasummit.us/ -- Feel free to contact us with any questions Bill Kenney, bill@meetroi.com MEET, http://meetroi.com/
TRANSCRIPT:
|
|
ACG NY 15th Annual Healthcare Conference | March 2023 | Mark Sullivan
MY SILO
DESCRIPTION:
Mark Sullivan, Chief Growth Officer & Partner of Stonehaven its down with ACG NY during the 15th Annual Healthcare Conference. The event assembled over 450 senior Middle Market Healthcare payers, providers, systems as well as top private equity, family office and strategic buyers representing billions of dollars ready to invest in the North American Healthcare Sector.
TRANSCRIPT:
|
|
Episode 15 - The Impact Technology Has On Business with Special Guest Mark Sullivan of Salesforce
MY SILO
DESCRIPTION:
Join us as we talk technology, digital currency, and business with Mark Sullivan - EVP at Salesforce https://www.thepavementgroup.com/
TRANSCRIPT:
|
|
Mark Sullivan: Data is the new currency but how do you spend it?
MY SILO
DESCRIPTION:
Data is widely accepted as an asset, the drive has begun to get the maximum return from it. Hear Mark Sullivan - Global CFO, IDC talk about Data Monetization with Reema Tendulkar on CNBC TV18's TECH @ work. ---------------------------------------------------------------------------------------- Follow IDC India on LinkedIn https://bit.ly/2H1Da8v & Twitter https://bit.ly/2TdBwHf for more updates.
TRANSCRIPT:
|
|
Getting There Together – Why Sharing is the Future | Anya Babbitt & Yale Zhang | TEDxWilmingtonSalon
MY SILO
DESCRIPTION:
In the future, the limiting factor will be available space. The Founders of SPLT draw from their personal experiences in creating their transportation platform and talk about the direction of the shared economy and how that will help reduce waste, increase sustainability, and bring about the shared transportation platforms of tomorrow. -- Anya Babbitt is the Founder & CEO. She has started multiple businesses and exited one. Anya is resilient, resourceful and a quick decision maker. Having written her thesis on the Kyoto Protocol, Anya is driven to work with cities, corporations and universities to align integrated services thereby reformatting cities of the future. Under Anya's leadership, SPLT has been recognized for 40+ awards and prizes such as the Hult Prize, Google Demo Day, Clean Energy Trust, and Accelerate Michigan as well as press in Huffington Post, Forbes and TechCrunch. SPLT has expanded to serve organizations in the United States, Latin America, and now Europe. Anya is passionate about social responsibility and environmental impact to create a more livable and breathable world with mobility access for all. Yale Zhang, Co-Founder, comes from a background in transportation and logistics, focusing on the warehousing and distribution of physical goods around the United States. He exited a multimillion dollar healthcare products distribution company. In his capacity as Vice President of Wintao Global, they secured multi-year software development contracts with major transportation companies including Dynamex, Datatrac, Marc Global (now a subsidiary of RedPrairie). This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
TRANSCRIPT:
|
|
Smart Phone Pulse Oximeter | Yale Zhang | Talks at Google
MY SILO
DESCRIPTION:
Yale Zhang is the founder of hardware start-up Safe Heart, which develops innovative wellness applications, hardware, and accessories. Their flagship product iOximeter is the first pulse oximeter to work on Android and iOS platforms, and a recent finalist on the Engadget Insert Coin competition. The iOximeter is a vital signs monitoring tool for smart phones. It is powered through the phone audio jack. Current features of the app include measurements of the oxygen saturation and heart rate, recording, and alarm functionality. Presentation will go over the conception, research, development, and commercialization of the iOximeter product. Future functionality road map will be revealed. A Q&A session will be held afterwards. The presentation will conclude with a live demo and a device giveaway.
TRANSCRIPT:
|
|
Yale Zhang, Co-Founder, SPLT - WCX 2018
MY SILO
DESCRIPTION:
WCX TV sits down with Yale Zhang, Co-Founder of SPLT, to learn about the work that SPLT is doing regarding shared mobility.
TRANSCRIPT:
|
|
Anya Babbit, Yale Zhang for SPLT | TEDxWilmington | Getting There Together
MY SILO
DESCRIPTION:
By: Jake Voorhees https://www.youtube.com/jakevoorhees Anya Babbitt is the Founder and CEO of Splitting Fares, Inc. (“SPLT”), an enterprise ridesharing platform changing the way people commute together. Ms. Babbitt is a marketing and brand strategist dedicated to fresh insights, authentic messaging and measurable results in sustainability. An experienced entrepreneur, Anya has founded and grown three successful companies and exited one. Anya Babbitt is not your typical entrepreneur. Number one, she is a women in a tech start-up, number two, she is the CEO and number three she is working in an area (transportation) that is dominated by men. Anya, however, is not concerned about the gender inequality or the odds of success–she is laser focused on changing the way people meet and move in urban environments. As a German immigrant, her great grandfather achieved enough success in the United States that he was able to send his five sons to Princeton Prep School and consequently to Princeton University. As a result, Anya believes that the United States provides the best opportunities for innovation and entrepreneurship. She understands and appreciates the supportive environment that allows and encourages her to build and scale her world-changing venture. Anya hopes to inspire other women to pursue entrepreneurship and contribute to creating jobs and socially innovative ventures. Anya has guided SPLT from a small startup in NYC to being chosen for Techstars Mobility 2015 driven by Detroit. Her professional experience spans over 15 years working in the advertising, corporate communications, marketing, product design and sales sector primarily in Boston and New York City, including several years engaged in corporate brand development for multiple brands in domestic and worldwide locations. As a marketing entrepreneur, Anya has successfully provided marketing strategies to such notable institutions and luxury brands as WilmerHale (formerly Hale & Dorr), Trilogy Capital Partners, the Winter Equestrian Festival (WEF), Vicomte A., Hermes, Cartier, Bombardier, Fraser Yachts, L’Oreal, Maybach, the Vicente Fox Center of Studies, Library and Museum, Citizens Energy Corporation and the international and domestic Polo Clubs Association. She has led large teams of individuals working under tight deadlines and with large committed budgets. Her ability to plan ahead and execute under pressure allowed her to excel within the closely tied luxury goods market creating clients out of partnership opportunities. Throughout her career she has been engaged in testing the connection between purpose driven leadership and competitive bottom line performance. As a result, her teams have consistently outperformed peers in both growth and profitability. Since 2014, she has devoted her full attention to the emerging field of social and environmental sustainability, launching SPLT. Yale Zhang is a co-founder of Splitting Fares, Inc. Prior to entering the world of entrepreneurship, Yale’s background was in transportation and logistics, focusing on the warehousing and distribution of physical goods around the United States. In his capacity as Vice President of Wintao Global, they secured multi-year software development contracts with major transportation companies including Dynamex, Datatrac, Marc Global (now a subsidiary of RedPrairie). The insight into these transportation entities allowed Yale to leave and in 2007 start Clinical Guard, his first product distribution company, in medical supplies. The company has grown from an initial annual revenue of $400K to now $3M. Later, he started a medical device innovations company, Safe Heart USA, Inc, focused on creating vital signs monitoring hardware that works in coordination with smartphones running Android and iOS. As the CEO of Safe Heart, Yale has overseen the successful commercialization of research from Oxford University, Emory University, the successful raising of grants from the Atlantic Pediatric Device Consortium, and finally, in raising capital to initially fund a newly emerging business venture. Although Yale has achieved a certain level of success with his involvement in medical devices, his primary passion has always been transportation systems, specifically autonomous vehicles. Yale believes that ongoing technology research by many private and public companies will lead to car ownership reduction as vehicles become autonomous. When that happens, extraordinary opportunities arise for people to share vehicles. He joins SPLT with the intent to help change the behavior of people so that they are comfortable with sharing rides with other people so that everyone will be ready when the autonomous vehicle economy arrives.
TRANSCRIPT:
|
|
PTSD and Pain – Dr. Mark Sullivan
MY SILO
DESCRIPTION:
PTSD and Pain - A presentation by Dr. Mark Sullivan at the Oregon Pain Guidance conference: 4th Annual Thoughtful Approach to Chronic Pain: New Horizons, What Clearly Works
TRANSCRIPT:
|
|
Online Events Made Simple LIVE with Mark Sullivan
MY SILO
DESCRIPTION:
TRANSCRIPT:
|